You can buy or sell ZIOP and other stocks, options, ETFs, and crypto commission-free!
ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. Read More The company was founded on September 9, 2003 and is headquartered in Boston, MA.
52 Week High
52 Week Low
Seeking AlphaMay 8
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2019 Results - Earnings Call Transcript
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Christopher Taylor - VP, IR David Mauney - President Laurence Cooper - CEO & Director Conference Call Participants Reni Benjamin - Raymond James & Associates Eric Joseph - JPMorgan Chase & Co. Swayampakula Ramakanth - H.C. Wainwright & Co. I-Eh Jen - Laidlaw & Company Thomas Flaten - Lake Street Capital Markets Operator Good afternoon, ladies and gentlemen, and welcome to the Ziopha...
Yahoo FinanceMay 8
ZIOPHARM Oncology, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 8, 2019 / ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-D0C85F04B79EE To receive updates for this company you can register by emailing firstname.lastname@example.org or by clicking get investment info from the company's profile. About Investor Network...
Yahoo FinanceMay 1
Ziopharm Oncology to Host Conference Call to Discuss First Quarter 2019 Financial Results on May 8, 2019
BOSTON, May 01, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (ZIOP) today announced that management will host a conference call and webcast on Wednesday, May 8, at 4:30 p.m. ET to provide a corporate update and discuss financial results for the first quarter ended March 31, 2019. The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international). The passcode for the conference call is 9185154. To access the live webcast or the subsequent archived recording, visit...
Expected Aug 8, After Hours